Monoclonal CGRP- (R) antibodies for the prevention of migraine

A new era in migraine prophylaxis has begun with the launch of antibodies blocking the Calcitonin-Gene Related Peptide (CGRP) pathway. These substances act across the entire frequency spectrum of migraine and have a tolerability superior to any other class of migraine preventatives based on our clin...

Full description

Bibliographic Details
Main Author: Uwe Reuter
Format: Article
Language:English
Published: Whitehouse Publishing 2023-03-01
Series:Advances in Clinical Neuroscience & Rehabilitation
Online Access:https://acnr.co.uk/articles/monoclonal-cgrp-r-antibodies-for-the-prevention-of-migraine/